Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP001322

Drug Information
NameAmphotericin B    
SynonymsAmphotherizin [German]; Amphotericinum B; Prestwick0_000410; Amphotericin B, Streptomyces sp.; Amphotericin B, Lipid-based; Amphotericine B [INN-French]; Abelecet; SMR001566780; Fungisome; Fungizone (TN); NCI60_004288; NS 718; MolPort-006-392-260; NCGC00090808-01; LMPK06000002; CHEMBL1200646; Amphomoronal; NCI527017; C47H73NO17; Amphotericinum; Amfotericina B [INN-Spanish]; UNII-7XU7A7DROE; AC1NTQ32; MLS002702966; C06573; KBio2_003119; Amphotericin B Colloidal Dispersion; Amphotec (TN); amphotericin B liposomal; AB00513832; 12633-72-6; KBioGR_002298; D00203; AC1NY9JC; CHEMBL267345; AC1L70KF; CID6713692; SinuNase; Spectrum2_000818; AC1L24V6; Prestwick3_000410; NSC-527017; Amphotericine B; BIDD:GT0351; CHEBI:2682; 54482-28-9; HMS1569A22; Amphotericin B [USAN:INN:JAN]; CID10677275; Spectrum4_001779; Amfotericina B; CID10629638; Amphortericin B; NCGC00179595-01; CID10533925; 30782-62-8; CCRIS 5963; Ambisome; Amphotericin B Cholesterol Dispersion; NSC 527017; LS-187721; Amphozone; NCGC00098014-01; CID9919339; EINECS 215-742-2; KBioSS_000551; Prestwick1_000410; SPBio_002279; Fungizone; Amphotericinum B [INN-Latin]; CID352546; AC1L1CN2; SPBio_000715; Amphotherizin; ST50999656; NSC527017; ABLC; Abelcet; Amphotericin; AC1O8PFK; 1397-89-3; AC1L73U6; amophotericin B; Fungilin; Amphocin; Ambap1397-89-3; AI3-26528; CID6604295; Amphotericin B (JP15/USP/INN); amphotericin b; I06-0257; DB00681; Liposomal Amphotericin B; BPBio1_000374; 5-18-10-00525 (Beilstein Handbook Reference); Prestwick2_000410; CID5280965; CID1972; Halizon; AMPH-B; KBio2_005687; AC1O7GCZ; AC1O8FQV; AmBisome (TN); CID14956; HSDB 3008; Amphotec; SMP1_000302; Amphotericin-B; AC1NUQG4; CID5386092; Ampho-Moronal; CID5771695; CID5458486; CID6708817; KBio2_000551; HSDB 3008 IAB; 8055-20-7; Fungisone; Prestwick_721; LNS-AmB; CID354192; NCGC00014913; NKTR-024; LS-93; AC1NQXTD; SpecPlus_000949; BSPBio_000340; DivK1c_007045; Spectrum_000111; NCIStruc2_000920; NCIStruc1_001042; Amphotericin .BETA.; BRN 0078342; KBio1_001989; Mysteclin-F    
Trade NameFungilin; Fungizone; Abelcet; AmBisome; Fungisome; Amphocil; Amphotec    
IndicationFungal infectionsApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAntifungal Agents    
CAS NumberCAS 1397-89-3
FormularC47H73NO17    
PubChem Compound IDCID 5771695.    
PubChem Substance IDSID 4254360.    
SuperDrug ATC IDA01AB04;    
SuperDrug CAS ID001397893;    
TargetFungal outer membraneBinder[2][3]
Ref 1FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 050724 To Reference
Ref 2Synthesis and investigation of tryptophan-amphotericin B conjugates. Chembiochem. 2009 Jul 6;10(10):1617-20. To Reference
Ref 3Antifungal agents: mode of action in yeast cells. Rev Esp Quimioter. 2006 Jun;19(2):130-9. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543